Ignite Creation Date:
2025-12-24 @ 5:41 PM
Ignite Modification Date:
2026-01-01 @ 12:32 PM
Study NCT ID:
NCT00361868
Status:
TERMINATED
Last Update Posted:
2008-06-27
First Post:
2006-08-08
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Fenofibrate and Metformin Fixed Combination vs Rosiglitazone - FAME ROSI
Sponsor:
Solvay Pharmaceuticals
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
C LF23-0121 05 01
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
None
Responsible Party Affiliation:
Old Name:
Michel Conte
Old Organization:
Solvay Pharmaceuticals